How Has the Over-The-Counter (OTC) Pet Medication Market Size Evolved in Recent Years?
The over-the-counter (otc) pet medication market has seen considerable growth due to a variety of factors.
• The over-the-counter (OTC) pet medication market has grown significantly in recent years. It will increase from $8.73 billion in 2024 to $9.3 billion in 2025, at a compound annual growth rate (CAGR) of 6.5%.
The growth is driven by rising trends in pet humanization, greater demand for convenience in pet care, expanded retail channels, higher pet ownership rates, and changes in the regulatory landscape.
What Are The Predictions for The Over-The-Counter (OTC) Pet Medication Market in the Coming Years?
The over-the-counter (otc) pet medication market is expected to maintain its strong growth trajectory in upcoming years.
• The OTC pet medication market is expected to grow to $11.81 billion by 2029, at a CAGR of 6.2%.
Growth is driven by changing consumer attitudes toward pet health, increased awareness of preventive care, a rise in pet ownership, expanding product offerings, and a greater demand for OTC pet medications. Trends include telemedicine integration in veterinary care, expansion of natural and organic product lines, personalized pet health solutions, growth of e-commerce platforms, and a focus on preventive care.
Which Drivers Are Accelerating Growth In The Over-The-Counter (OTC) Pet Medication Market?
Increased rates of pet ownership are anticipated to spur the expansion of the over-the-counter (OTC) pet medication market. Legal and ethical care for a domesticated companion animal is encompassed in pet ownership. This trend is growing due to factors such as companionship and emotional support, enhanced living standards, urbanization, evolving family structures, and a heightened understanding of the health and welfare benefits of owning a pet. OTC pet medications present various advantages to pet owners, rendering their pet care routines more manageable and straightforward. These medications, known for their easy accessibility and affordability, promote responsible pet care by providing speedy solutions for prevalent health issues. For example, the American Pet Products Association, a US non-profit, reported that as of October 2023, 86.9 million US homes had pets, showing an increase from 66% of households in 2022. Furthermore, Animal Medicines Australia, an organization representing animal health, noted in November 2022 that 69% of Australian households in 2022 had pets. Therefore, an upsurge in pet ownership is steering the growth of the OTC pet medication market.
What Are The Core Segments Of The Global Over-The-Counter (OTC) Pet Medication Market?
The over-the-counter (OTC) pet medication market covered in this report is segmented –
1) By Medication: Flea And Tick Control, Wormers And Dewormers, Dental Care, Nutritional Supplements, Skin And Coat Care, Pain And Allergy Relief, Other Medications
2) By Pet: Dogs, Cats, Birds, Fishes And Reptiles, Other Pets
3) By Form: Chews And Treats, Capsule And Ointment, Sprays, Other Forms
4) By Distribution Channel: Drug And Pharmacy Stores, Pet Specialty Stores, Veterinary Clinics And Hospitals, Online Retailers, Other Distribution Channels
Subsegments:
1) By Flea And Tick Control: Topical Treatments, Oral Medications, Shampoos And Sprays
2) By Wormers And Dewormers: Oral Wormers, Topical Dewormers, Injectable Dewormers
3) By Dental Care: Toothpaste And Toothbrushes, Dental Chews And Treats, Oral Rinses And Sprays
4) By Nutritional Supplements: Vitamins And Minerals, Joint Health Supplements, Digestive Health Supplements, Immune Support Supplements
5) By Skin And Coat Care: Shampoos And Conditioners, Topical Creams And Sprays, Flea And Tick Sprays
6) By Pain And Allergy Relief: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Antihistamines, Steroid Creams And Ointments
7) By Other Medications: Digestive Aids, Anti-Anxiety Medications, Eye And Ear Care Products
Pre-Book The Over-The-Counter (OTC) Pet Medication Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Over-The-Counter (OTC) Pet Medication Market?
Prominent corporations in the over-the-counter (OTC) pet medication market are focusing their efforts on innovating new products, including the development of the first-ever monoclonal antibody, in order to maintain their market prominence. A monoclonal antibody refers to an antibody generated by identical immune cells cloned from a singular parent cell. For example, in October 2023, Zoetis Inc., a pharmaceutical company based in the US, introduced the Bedinvetmab injection and Oclacitinib chewable tablets, both approved by the US's Food and Drug Administration (FDA). The Oclacitinib chewable tablets, which received FDA approval, are used to manage pruritus related to allergic dermatitis and atopic dermatitis in dogs that are at least one year old. This marked the debut of the first chewable remedy for allergic itch and inflammation in US dogs. Veterinarians across the United States now have these veterinary medications available for prescription.
Who Are the Key Players In The Over-The-Counter (OTC) Pet Medication Market?
Major companies operating in the over-the-counter (OTC) pet medication market are:
• Pfizer Inc.
• Merck & Co. Inc.
• Bayer AG
• Novartis AG
• Zoetis Inc.
• Boehringer Ingelheim IN
• Elanco Animal Health Incorporated
• VCA Animal Hospital Inc.
• Ceva Sante Animale S.A
• Virbac S.A.
• PetIQ Holdings LLC
• Vetoquinol S.A
• Norbrook Laboratories Limited
• Bimeda Inc.
• Med-Vet International Inc.
• Sergeant’s Pet Care Products Inc.
• Advecta
• Zesty Paws
• Durvet Inc.
• Pet King Brands
• Animax Ltd.
• PetArmor
What Are The Regional Insights Into The Over-The-Counter (OTC) Pet Medication Market?
North America was the largest region in the over-the-counter (OTC) pet medication market in 2024. The regions covered in the over-the-counter (OTC) pet medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
